Lilavati Hospital Opens Overseas Centre In Kazakhstan

Lilavati Hospital and Research Centre is set to open its first overseas facility in Kazakhstan in September, as part of a strategy to attract more international patients to India for advanced treatment. The Kazakhstan centre will operate as a super-speciality outpatient facility, offering consultations, second opinions and treatment planning in various specialties such as oncology, cardiac sciences, and neurology.

The centre will refer patients requiring complex procedures or major surgeries to Lilavati Hospital’s Bandra facility in Mumbai. This move is part of India's growing focus on medical tourism, with the government seeking to position itself as a global Medical Value Travel (MVT) destination.

According to government data, 5.07 lakh foreign nationals came to India for medical treatment in 2025, accounting for about 5.5% of total foreign tourist arrivals. Bangladesh was the largest source market, followed by countries including Iraq, Uzbekistan, Somalia, Turkmenistan, and Oman.

Dr Ravindra Karanjekar, CEO of Lilavati Hospital and Research Centre, said the Kazakhstan facility would serve as a gateway for the hospital’s planned expansion across Central Asia. The hospital is evaluating opportunities in Uzbekistan, Oman, Mauritius, and Sri Lanka.

Lilavati’s expansion comes amid a wider push by states and healthcare companies to build international-facing medical infrastructure. In Maharashtra, the government has backed the development of the Navi Mumbai International MediCity, envisioned as a global healthcare, research, education, and wellness hub.

Lilavati plans to add around 3,000 beds over the next five years, including a 300-bed cancer hospital in Ahmedabad and facilities in New Delhi and Indore. The hospital’s expansion is expected to make Mumbai a destination for high-end procedures, complex surgeries, and specialised care, turning medical tourism into a significant new growth avenue for the healthcare sector.

The move is also expected to boost the economy, with medical tourism becoming a major contributor to India's foreign exchange earnings. As the healthcare sector continues to grow, hospitals are now seeking to make Mumbai a hub for medical tourism, offering high-quality and affordable treatment options to patients from around the world.

In recent years, there has been a significant increase in the number of foreign patients coming to India for medical treatment. This is due to the country's high-quality healthcare infrastructure, skilled medical professionals, and competitive pricing. With the opening of the Kazakhstan centre, Lilavati Hospital is well-positioned to tap into this growing market and establish itself as a major player in the medical tourism sector.

The hospital’s expansion plans are also expected to create new job opportunities in the healthcare sector, both in India and abroad. As the demand for medical tourism continues to grow, hospitals like Lilavati will play a crucial role in providing high-quality treatment options to patients from around the world.

In conclusion, the opening of Lilavati Hospital’s overseas centre in Kazakhstan marks a significant milestone in the hospital’s expansion plans and is expected to boost medical tourism in India. With its high-quality healthcare infrastructure and skilled medical professionals, Mumbai is well-positioned to become a major hub for medical tourism, offering patients from around the world access to advanced treatment options at affordable prices.